Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-02
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥665.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥2.66T2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥581.5bn2022-01-01 → 2022-03-31Cons.Revenue IFRS
Operating income¥206.4bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥178.4bn2022-01-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax¥183.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥593.5bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥174.7bn2022-01-01 → 2022-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥144.7bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥442.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥124.1bn2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥145.2bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥444.2bn2022-01-01 → 2022-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥124.6bn2022-01-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥6.35Tat 2023-03-31Cons.Assets IFRS
Total assets¥6.55Tat 2022-12-31Cons.Assets IFRS
Total assets¥5.75Tat 2022-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.76Tat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥2.93Tat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥3.59Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.62Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥2.98Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥2.89Tat 2021-12-31dCons.Equity IFRS
Equity (owners)¥3.51Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.54Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥665.2bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥866.9bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥655.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥721.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥55.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥483.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥39.0bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥41.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥101.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥22.7bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥196.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥306.2bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥116.8bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥81.522023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥249.452022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥69.942022-01-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥81.492023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥249.362022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥69.912022-01-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio55.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio54.1%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥654m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.6bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2023-01-01 → 2023-03-31¥604.4bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2023-01-01 → 2023-03-31¥604.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥61m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥208.8bn
—segment totalrevenue2023-01-01 → 2023-03-31¥664.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥664.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥69m
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥217.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-03-31¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-03-31¥611m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-03-31¥1.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.8bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-03-31−¥1.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-03-31−¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2022-01-01 → 2022-03-31¥21.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2022-01-01 → 2022-03-31¥21.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2022-01-01 → 2022-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2022-01-01 → 2022-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥0
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥412m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥412m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥318m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2022-01-01 → 2022-03-31¥524.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2022-01-01 → 2022-03-31¥523.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥59m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥197.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥197.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥181.3bn
—segment totalrevenue2022-01-01 → 2022-03-31¥581.0bn
—segment totalrevenue external2022-01-01 → 2022-03-31¥580.9bn
—segment totalrevenue intersegment2022-01-01 → 2022-03-31¥59m
—segment totalsegment profit2022-01-01 → 2022-03-31¥202.3bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥202.3bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥186.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 843
ItemContextValueUnit
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember1000000JPY
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember1000000JPY
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember19000000JPY
Changes in ownership interest in subsidiaries ss IFRSCurrentYTDDuration20000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-232000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember232000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration-JPY
Other ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Other ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember688000000JPY
Other ss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-JPY
Other ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember688000000JPY
Other ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-JPY
Other ss IFRSCurrentYTDDuration688000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember344000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RetainedEarningsIFRSMember-200358000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-199869000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-954000000JPY
Total transactions with owners IFRSCurrentYTDDuration-200823000000JPY
Equity IFRSCurrentQuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember126692000000JPY
Equity IFRSCurrentQuarterInstant_RetainedEarningsIFRSMember3034234000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember3507288000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember78962000000JPY
Equity IFRSCurrentQuarterInstant3586249000000JPY
Profit loss before tax IFRSPrior1YTDDuration174699000000JPY
Profit loss before tax IFRSCurrentYTDDuration183146000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration46372000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration42230000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration110000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration756000000JPY
Interest and dividend income ope cf IFRSPrior1YTDDuration-3222000000JPY
Interest and dividend income ope cf IFRSCurrentYTDDuration-7479000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration6092000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration6811000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration-816000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration-1299000000JPY
Gains losses on sale and disposal of property plant and equipment intangible assets and investment property ope cf IFRSPrior1YTDDuration-741000000JPY
Gains losses on sale and disposal of property plant and equipment intangible assets and investment property ope cf IFRSCurrentYTDDuration59000000JPY
Decrease increase in trade and other receivables ope cf IFRSPrior1YTDDuration22904000000JPY
Decrease increase in trade and other receivables ope cf IFRSCurrentYTDDuration6099000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-2262000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-14370000000JPY
Increase decrease in trade and other payables ope cf IFRSPrior1YTDDuration-77420000000JPY
Increase decrease in trade and other payables ope cf IFRSCurrentYTDDuration-62781000000JPY
Increase decrease in retirement benefit liability ope cf IFRSPrior1YTDDuration-5369000000JPY
Increase decrease in retirement benefit liability ope cf IFRSCurrentYTDDuration-5529000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass